11 November 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice on seven medicines.

Axicabtagene ciloleucel (Yescarta) was accepted for the treatment of adult patients with diffuse large B-cell lymphoma or high-grade B-cell lymphoma, types of blood cancers, when they have received only one line of therapy.

Read SMC press release